IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on November 1, 2008
(Investigative Ophthalmology and Visual Science. )
© 2008 by The Association for Research in Vision and Ophthalmology, Inc.
doi:10.1167/iovs.07-1154

This Article
Right arrow Full Text (P<P[PDF])
Right arrow All Versions of this Article:
iovs.07-1154v1
49/11/5008    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by She, H.
Right arrow Articles by Miller, J. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by She, H.
Right arrow Articles by Miller, J. W.

Article

Dexamethasone Reduces Photoreceptor Damage Caused by Photodynamic Therapy in a Rat Model of Choroidal Neovascularization

Haicheng She 1, Toru Nakazawa 2, Akihisa Matsubara 2, Edward Connolly 2, Toshio Hisatomi 2, Kousuke Noda 2, Ivana K. Kim 2, Evangelos S. Gragoudas 2, and Joan W. Miller 2*

1 Angiogenesis and Laser Laboratories, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Massachusetts, United States; Beijing Tongren Eye Center,Beijing Tongren Hospital, Capital Medical University, Beijing, China
2 Angiogenesis and Laser Laboratories, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Massachusetts, United States

* To whom correspondence should be addressed. E-mail: jwmiller{at}meei.harvard.edu.


   Abstract

Purpose. To study whether corticosteroids protect photoreceptors when combined with photodynamic therapy (PDT) in a laser-induced model of choroidal neovascularization (CNV). Methods. PDT was performed in 36 Brown-Norway rats 2 weeks after laser induction of CNV. The expressional change of several cytokines and chemokines in the CNV lesions after PDT was measured by real-time PCR in combination with laser-capture microdissection. Immunostaining for monocyte chemoattractant protein1(MCP-1), C-C chemokine receptor 2(CCR2), interleukin 1 beta(IL-1{beta}) and myeloperoxidase(MPO) were performed. To study the effect of corticosteroids in combination with PDT, either dexamethasone(100mg/kg) or control was injected intraperitoneally 1 h before PDT. Animals were sacrificed 24 h or 1 week after PDT. CNV was examined by fluorescein angiography and choroidal flatmount. Photoreceptor degeneration was evaluated by TUNEL assay. Results. MCP-1 and IL-1{beta} was increased in CNV lesions 24 h after PDT. CCR2 was also expressed in laser-induced CNV but did not increase after PDT. Twenty-four hours after PDT, MPO positive cells were noted in CNV lesions. Dexamethasone-treated animals had significantly fewer TUNEL positive cells in the photoreceptor layer compared to the controls(p<0.05) after PDT. Fluorescein angiographic grading of CNV closure 6 days after PDT showed a closure rate in the dexamethasone-treated group of 31%(15/48 lesions) compared to 10%(4/42 lesions) in the control group(p<0.05). CNV size was significantly smaller in the dexamethasone-treated group 1 week after PDT compared to control(p<0.05). Conclusions. Systemic administration of dexamethasone combined with PDT reduces photoreceptor apoptosis, increases angiographic closure and reduces CNV size compared to PDT alone in a rat model.

Key Words: age-related macular degeneration, apoptosis, angiogenesis, corticosteroids, photodynamic therapy, animal model







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2008 by the Association for Research in Vision and Ophthalmology